Plus Therapeutics IncPSTV
Price$3.87

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $5.2M-2.9% YoYTTM through 31 Mar 2026
Net Income -$11MTTM through 31 Mar 2026
Free Cash Flow -$21.7MTTM through 31 Mar 2026

Margins

Current
Operating Margin-692.5%
Net Margin-675.7%

Returns

-58.1%ROE
-34.9%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio2.52x
Net Debt-$15.1Mnet cash position
Cash & Equivalents$3M

Quality Metrics

FCF Margin-419.1%
Rule of 40-397.7
Earnings-Beat Rate50.0%

Dividend

No dividend
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.